These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12108031)

  • 41. Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast.
    Boland GP; McKeown A; Chan KC; Prasad R; Knox WF; Bundred NJ
    Br J Cancer; 2003 Jul; 89(2):277-83. PubMed ID: 12865917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PLC-beta2 is highly expressed in breast cancer and is associated with a poor outcome: a study on tissue microarrays.
    Bertagnolo V; Benedusi M; Querzoli P; Pedriali M; Magri E; Brugnoli F; Capitani S
    Int J Oncol; 2006 Apr; 28(4):863-72. PubMed ID: 16525635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sex steroid receptors in gynecologic cancer.
    Hoffman PG; Siiteri PK
    Obstet Gynecol; 1980 May; 55(5):648-52. PubMed ID: 6988749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
    Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy.
    Chrapusta SJ; Giermek J; Pieńkowski T
    Med Sci Monit; 2004 Oct; 10(10):CR577-86. PubMed ID: 15448598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen and progesterone receptors in breast cancer. Immunohistochemical assay on scraping material.
    Frigo B; Pilotti S; Coradini D; La Malfa G; Rilke F
    Anal Quant Cytol Histol; 1992 Apr; 14(2):129-36. PubMed ID: 1590896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of steroid hormone-dependency of tumours utilizing tissue sections. Survey of histochemical techniques and their application in surgical pathology.
    De Goeij TF; Bosman FT; Berns EM
    J Pathol; 1986 Jul; 149(3):163-72. PubMed ID: 3528443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
    Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I
    Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients.
    Liu ZB; Liu GY; Yang WT; Di GH; Lu JS; Shen KW; Shen ZZ; Shao ZM; Wu J
    Oncol Rep; 2008 Oct; 20(4):987-94. PubMed ID: 18813844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?
    Arnould L; Coudert B; Fumoleau P
    J Clin Oncol; 2009 Jun; 27(16):2733; author reply 2734-5. PubMed ID: 19380432
    [No Abstract]   [Full Text] [Related]  

  • 53. Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study.
    Martín De Las Mulas J; Millán Y; Bautista MJ; Pérez J; Carrasco L
    Res Vet Sci; 2000 Feb; 68(1):15-21. PubMed ID: 10684753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
    Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
    J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative evaluation of proliferative activity of breast tumors of different estrogen-progesterone receptor status].
    Ellinidi VN; Anikeeva NV; Goncharova OA; Krasnozhon DA
    Vopr Onkol; 2005; 51(2):197-9. PubMed ID: 16223000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oestrogen receptors revisited: long-term follow up of over five thousand breast cancer patients.
    Hähnel R; Spilsbury K
    ANZ J Surg; 2004 Nov; 74(11):957-60. PubMed ID: 15550082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.
    Stendahl M; Rydén L; Nordenskjöld B; Jönsson PE; Landberg G; Jirström K
    Clin Cancer Res; 2006 Aug; 12(15):4614-8. PubMed ID: 16899609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.
    Derin D; Eralp Y; Ozluk Y; Yavuz E; Guney N; Saip P; Igci A; Ozmen V; Kücücük S; Aslay I; Aydiner A; Topuz E
    Cancer Invest; 2008 Aug; 26(7):671-9. PubMed ID: 18608215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Menstrual cycle and hormone receptor status in breast cancer patients.
    Atalay C; Kanliöz M; Altinok M
    Neoplasma; 2002; 49(4):278. PubMed ID: 12382029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Steroid receptors in breast cancer.
    Drafta D
    Endocrinologie; 1980; 18(2):117-21. PubMed ID: 7384734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.